Search
for
Sort by
Research 91–120 of 1000+
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- SAFETY AND THERAPEUTIC OUTCOMES OF COMBINED PLATELET-RICH PLASMA AND TOPICAL MINOXIDIL THERAPY IN PATIENTS WITH CHRONIC HAIR FALL
- Real‐World Clinical Outcomes With a 1% SeleniumSulfide/1% Salicylic Acid Shampoo Formulation for Seborrheic Dermatitis and Dandruff: A Multicenter Observational Study
- Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute
- Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata
- Poster 252 Patient Registry of Outcomes in Spasticity Care
- Alopecia areata-successful outcome with microneedling and triamcinolone acetonide
- Clinical development and management of adverse events associated with FGFR inhibitors
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- Pilot study of topical management of folliculitis: clinical outcomes and safety in routine practice
- THE INTERDISCIPLINARY IMPACT OF ISOTRETINOIN THERAPY ON ACNE VULGARIS: A COMPREHENSIVE REVIEW OF ADVERSE EFFECTS AND MONITORING PROTOCOLS
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- Six-Month Quality of Life and Health Outcomes After Bariatric Surgery: A Prospective Cohort Study from Latvia
- Efficacy, safety, and patient-reported outcomes of scalp micropigmentation in scarring alopecia
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Laser-based interventions for scarring alopecia: a meta-analytic review of clinical outcomes
- Hormone therapy in the treatment of breast cancer and main outcomes in sexuality
- Evaluation of Short-Term Efficacy and Long-Term Oncologi-Cal Outcomes of Different Paclitaxels Plus Platinum Regi-Mens in the Treatment of Serous Ovarian Cancer—A Real World Study
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Efluvio anageno inducido por azatioprina: reporte de efecto adverso infrecuente
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Trichoscopic Markers and Clinical Response Patterns With Ritlecitinib in Severe Alopecia Areata: 24‐Week Outcomes From a Prospective Real‐World Cohort
- Prognosis, treatment, and disease outcomes in frontal fibrosing alopecia: A retrospective review of 92 cases
- A single-blinded, randomized controlled study of the use of autologous platelet rich plasma (PRP) as a medium to reduce scalp hair transplant adverse effects
- Intradiscal platelet-rich plasma for discogenic low back pain: a prospective cohort study of early clinical outcomes and quantitative MRI findings
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes